Download PDF
Thromb Haemost 2008; 99(05): 969
DOI: 10.1160/TH08-03-0198
Letters to the Editor
Schattauer GmbH

Rebuttal to "Aspirin response variability assessed with the PFA-100 device" by Reny et al.

Marilena Crescente
1   Research Laboratories, "John Paul II" Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
,
Augusto Di Castelnuovo
1   Research Laboratories, "John Paul II" Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
,
Licia Iacoviello
1   Research Laboratories, "John Paul II" Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
,
Giovanni de Gaetano
1   Research Laboratories, "John Paul II" Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
,
Chiara Cerletti
1   Research Laboratories, "John Paul II" Center for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
› Author Affiliations
Further Information

Publication History

Received 29 March 2008

Accepted 01 April 2008

Publication Date:
30 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Snoep JD, Hovens MM, Eikenboom JC. et al. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 1593-1599.
    CrossrefPubMedGoogle Scholar
  • 2 Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002; 324: 71-86.
    CrossrefPubMedGoogle Scholar
  • 3 Reny JL, Quéré I, de Moerloose P. et al. Aspirin response variability assessed with the PFA-100 device. Thromb Haemost 2008; 99: 968-969.
    Article in Thieme ConnectPubMedGoogle Scholar